RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 111 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $61,000 | +32.6% | 11,284 | +13.7% | 0.00% | – |
Q1 2016 | $46,000 | +21.1% | 9,921 | +36.6% | 0.00% | – |
Q4 2015 | $38,000 | -33.3% | 7,263 | -22.5% | 0.00% | – |
Q3 2015 | $57,000 | +23.9% | 9,367 | +221.7% | 0.00% | – |
Q2 2015 | $46,000 | +119.0% | 2,912 | +51.2% | 0.00% | – |
Q1 2015 | $21,000 | +5.0% | 1,926 | +1.0% | 0.00% | – |
Q4 2014 | $20,000 | -4.8% | 1,906 | -14.6% | 0.00% | – |
Q3 2014 | $21,000 | -19.2% | 2,231 | -1.8% | 0.00% | – |
Q2 2014 | $26,000 | +8.3% | 2,272 | -4.9% | 0.00% | – |
Q1 2014 | $24,000 | -17.2% | 2,389 | +7.4% | 0.00% | – |
Q4 2013 | $29,000 | -71.8% | 2,225 | -67.8% | 0.00% | -100.0% |
Q3 2013 | $103,000 | +212.1% | 6,911 | +93.6% | 0.00% | – |
Q2 2013 | $33,000 | – | 3,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
Birchview Capital, LP | 40,000 | $184,000 | 0.13% |